chevron_leftBack
As of 19 June 2026, Zhejiang Wecome Pharmaceutical Company Ltd. has a market cap of $578.03M USD, ranking #14196 globally and #4384 in China.
It ranks #1264 in the Healthcare sector, and #470 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$578.03MUSD
3.91B CNY
Enterprise Value
$582.64MUSD
3.94B CNY
Revenue (TTM)
$33.33MUSD
225.27M CNY
EBITDA (TTM)
-$3.36MUSD
-22.72M CNY
Net Income (TTM)
-$33.64MUSD
-227.34M CNY
EBITDA Margin
-10%
Profit Margin
-101%
PS Ratio
17.3
PB Ratio
4.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yang Liu
open_in_new
Employees
650
Founded
2000
Website
zjwk.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 3.9% | 4.7% | -0.9% | 1.3% | 17% | 94% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300878
浙江维康药业股份有限公司 Class A
ISIN: CNE1000047P9
Shares Out.:
Shares Outstanding:
142.051M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
28.58 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zhejiang Wecome Pharmaceutical Company Ltd.
Zhejiang Wecome Pharmaceutical Company Limited engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China. The company offers products in various forms, including hard capsules, tablets, granules, soft capsules, pills, and other dosage forms. It also operates the retail of pharmaceutical commercial products. The company was formerly known as Zhejiang Weikang Pharmaceutical Co., Ltd. Zhejiang Wecome Pharmaceutical Company Limited was founded in 2000 and is based in Lishui, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.99B
9K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.77B
9K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
5K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
3K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.56B
3K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
3K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
132K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
95K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
62K%
|
97.4
|
|
SIX: RO
|
$321.45B
56K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$287.52B
50K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.59B
47K%
218.9B CHF
|
20.5
|
chevron_leftBack